Abstract

Identification of novel therapeutic targets is required for developing alternate strategies to treat infections caused by the extensively drug-resistant bacterial pathogen, Acinetobacter baumannii. As capsular polysaccharide (CPS) is a prime virulence determinant required for evasion of host immune defenses, understanding the pathways for synthesis and assembly of this discrete cell-surface barrier is important. In this study, we assess cell-bound and cell-free CPS material from A. baumannii AB5075 wildtype and transposon library mutants and demonstrate that the Wzi outer membrane protein is required for the proper assembly of the CPS layer on the cell surface. Loss of Wzi resulted in an estimated 4.4-fold reduction in cell-associated CPS with a reciprocal increase in CPS material shed in the extracellular surrounds. Transmission electron microscopy revealed a disrupted CPS layer with sparse patches of CPS on the external face of the outer membrane when Wzi function was lost. However, this genotype did not have a significant effect on biofilm formation. Genetic analysis demonstrated that the wzi gene is ubiquitous in the species, though the nucleotide sequences were surprisingly diverse. Though divergence was not concomitant with variation at the CPS biosynthesis K locus, an association between wzi type and the first sugar of the CPS representing the base of the structure most likely to interact with Wzi was observed.

Highlights

  • Identification of novel therapeutic targets is required for developing alternate strategies to treat infections caused by the extensively drug-resistant bacterial pathogen, Acinetobacter baumannii

  • Whole genome sequences were further investigated for other differences from the wildtype AB5075-UW reference genome, and only one single nucleotide polymorphism (SNP) was identified in each genome assembly

  • The SNP was located away from any gene known to be involved in capsular polysaccharide (CPS) b­ iosynthesis[5], indicating that T26 mutants shared an isogenic background with the AB5075 wildtype

Read more

Summary

Introduction

Identification of novel therapeutic targets is required for developing alternate strategies to treat infections caused by the extensively drug-resistant bacterial pathogen, Acinetobacter baumannii. The success of the species as a serious global pathogen can be attributed to a highly plastic genome with significant mutation rates and frequent acquisition of genes that confer extensive antimicrobial resistance, increase virulence in the host, and/or enhance survival in unfavorable conditions over long ­periods[3,4]. These characteristics have favored the expansion of multi-drug resistant clonal lineages, including the two globally disseminated clones, global clone 1 (GC1) and global clone 2 (GC2), emphasizing a need to better understand mechanisms for virulence and survival in host and nosocomial contexts. Despite the structural variation, the exact mechanism for attachment of all CPS structures to the cell surface remains unknown

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call